Compare TTK HEALTHCARE with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE NOVARTIS TTK HEALTHCARE/
NOVARTIS
 
P/E (TTM) x 18.3 494.1 3.7% View Chart
P/BV x 1.5 28.7 5.1% View Chart
Dividend Yield % 1.1 1.6 66.0%  

Financials

 TTK HEALTHCARE   NOVARTIS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
NOVARTIS
Mar-18
TTK HEALTHCARE/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,215758 160.3%   
Low Rs610579 105.4%   
Sales per share (Unadj.) Rs444.4228.4 194.6%  
Earnings per share (Unadj.) Rs17.231.7 54.3%  
Cash flow per share (Unadj.) Rs27.632.8 84.3%  
Dividends per share (Unadj.) Rs5.0010.00 50.0%  
Dividend yield (eoy) %0.51.5 36.6%  
Book value per share (Unadj.) Rs177.9297.1 59.9%  
Shares outstanding (eoy) m14.1324.69 57.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.9 70.2%   
Avg P/E ratio x52.921.1 251.2%  
P/CF ratio (eoy) x33.020.4 161.9%  
Price / Book Value ratio x5.12.2 228.0%  
Dividend payout %29.031.5 92.0%   
Avg Mkt Cap Rs m12,89416,505 78.1%   
No. of employees `0002.30.7 346.1%   
Total wages/salary Rs m1,3071,445 90.4%   
Avg. sales/employee Rs Th2,715.78,441.3 32.2%   
Avg. wages/employee Rs Th565.32,163.6 26.1%   
Avg. net profit/employee Rs Th105.41,173.1 9.0%   
INCOME DATA
Net Sales Rs m6,2795,639 111.3%  
Other income Rs m781,718 4.5%   
Total revenues Rs m6,3567,357 86.4%   
Gross profit Rs m496-63 -793.0%  
Depreciation Rs m14725 579.8%   
Interest Rs m3455 61.1%   
Profit before tax Rs m3931,575 24.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m149792 18.8%   
Profit after tax Rs m244784 31.1%  
Gross profit margin %7.9-1.1 -712.1%  
Effective tax rate %37.950.3 75.5%   
Net profit margin %3.913.9 27.9%  
BALANCE SHEET DATA
Current assets Rs m2,7179,522 28.5%   
Current liabilities Rs m1,5713,296 47.7%   
Net working cap to sales %18.3110.4 16.5%  
Current ratio x1.72.9 59.9%  
Inventory Days Days3237 87.8%  
Debtors Days Days4728 164.1%  
Net fixed assets Rs m99146 2,154.3%   
Share capital Rs m141123 114.5%   
"Free" reserves Rs m2,3737,213 32.9%   
Net worth Rs m2,5147,336 34.3%   
Long term debt Rs m30-   
Total assets Rs m4,15811,105 37.4%  
Interest coverage x12.629.5 42.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.50.5 297.4%   
Return on assets %6.77.6 88.3%  
Return on equity %9.710.7 90.7%  
Return on capital %16.922.2 76.2%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22561 371.6%   
Fx outflow Rs m713,630 2.0%   
Net fx Rs m154-3,570 -4.3%   
CASH FLOW
From Operations Rs m1731,610 10.8%  
From Investments Rs m97687 14.0%  
From Financial Activity Rs m-307-2,677 11.5%  
Net Cashflow Rs m-38-380 9.9%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 2.0 185.0%  
FIIs % 5.2 1.6 325.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.5 120.0%  
Shareholders   12,723 41,647 30.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   WYETH LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  IPCA LABS  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 16, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS